To test this hypothesis, serum levels of s-Fas, Epo, inflammatory cytokines, anemia markers, and the need for red blood cell transfusion were determined and compared in critically ill patients with and without AKI, chronic hemodialysis patients and healthy volunteers. This evidence concerns the gene FAS and anemia.